Clinical Trials Insight: 700059334
Phase of Trial: Phase I
Latest Information Update: 25 Feb 2011
At a glance
- Drugs Exenatide; Glucagon-like peptide 1 agonist
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 25 Feb 2011 Status changed from recruiting to completed.
- 23 Feb 2011 Positive pharmacokinetic results released by TransPharma Medical, showing an extended pharmacokinetic profile with transdermal glucagon-like peptide-1 agonist, compared with exenatide.
- 16 Sep 2010 New trial record